US Sexually-Transmitted Disease Testing Market 2014: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
Complete report $4,500. DataPack (test volumes, sales forecasts, supplier shares) $2,900.
This new 278-page report from Venture Planning Group provides analysis of the US sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report presents detailed analysis of the STD market in the US, Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, and Syphilis. The report provides test volume and sales forecasts and market segment, including:
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the US.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group's proprietary data files was conducted.
Contains 278 pages and 18 tables
This new 278-page report from Venture Planning Group provides analysis of the US sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report presents detailed analysis of the STD market in the US, Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, and Syphilis. The report provides test volume and sales forecasts and market segment, including:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used for STD testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the US.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group's proprietary data files was conducted.
Contains 278 pages and 18 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier